HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
HIMSSCast: Promoting COVID-19 vaccine equity for all: Q1 US policy update
Government & Policy

HIMSSCast: Promoting COVID-19 vaccine equity for all: Q1 US policy update

34:39

HIMSS Media editors welcome the HIMSS Government Relations team to discuss the vaccine rollout, broadband, Biden appointees and more.

Read More
Read Less

Government & Policy - Similar Videos View more in Government & Policy

10:16

In 2026, plenty of new developments to track

For the year ahead, we'll be watching for precision medicine advances, cybersecurity challenges, policy shifts and, of course, continued evolution of AI-enabled care delivery, say the editors of the HIMSS Media brands.

In 2026, plenty of new developments to track
For the year ahead, we'll be watching for precision medicine advances, cybersecurity challenges, policy shifts and, of course, continued evolution of AI-enabled care delivery, say the editors of the HIMSS Media brands.
10:16
5:04

Elimination of inpatient-only procedures comes at a cost for hospitals

The phase-out of the Medicare Inpatient-Only list drives value and efficiency, but hospitals lose out on volume and revenue, says Allison Oakes, chief research officer for Trilliant Health.

Elimination of inpatient-only procedures comes at a cost for hospitals
The phase-out of the Medicare Inpatient-Only list drives value and efficiency, but hospitals lose out on volume and revenue, says Allison Oakes, chief research officer for Trilliant Health.
5:04
6:41

The need to move AI regulation faster

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

The need to move AI regulation faster
The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.
6:41